Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Pharma firm Algeta Q3 loss smaller than forecast

01:25 EST 6 Nov 2013 | Reuters

OSLO, Nov 6 (Reuters) - Norway's Algeta, which has developed a novel prostate cancer drug with Germany's Bayer , reported a smaller-than-expected loss on Wednesday and raised slightly its estimates for 2013 revenues and marketing costs.

Original Article: Pharma firm Algeta Q3 loss smaller than forecast

NEXT ARTICLE

More From BioPortfolio on "Pharma firm Algeta Q3 loss smaller than forecast"

Search BioPortfolio:
Advertisement
Advertisement

Searches Linking to this Story